High cure rates and reduced long-term toxicity in pediatric Hodgkin’s disease: The German-Austrian multicenter trial DAL-HD-90. - Schellong,G.; Pötter,R.; Brämswig,J.; Wagner,W.; Prott,F-J.; Dörffel,W.; Körholz,D.; Mann,G.; Rath,B.; Reiter,A.; Weissbach,G.; Riepenhausen,M.; et al. (J Clin Oncol, 1999)